Successful Management of Antibody-Mediated Cardiac Allograft Rejection With Combined Immunoadsorption and Anti-CD20 Monoclonal Antibody Treatment: Case Report and Literature Review

Journal of Heart and Lung Transplantation

Volumn 26, Issue 5, 2007, Pages 511-515

  Kaczmarek, Ingo ^a   Deutsch, Marcus Andre ^a   Sadoni, Sebastian ^a   Brenner, Paolo ^a   Schmauss, Daniel ^a   Daebritz, Sabine H ^a   Weiss, Max ^a   Meiser, Bruno M ^a   Reichart, Bruno ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; IMMUNOLOGIC AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THERASORB; UNCLASSIFIED DRUG;

ADULT; ANAPHYLAXIS; ARTICLE; BLOOD CELL COUNT; CARDIAC GRAFT REJECTION; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; LITERATURE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOTHERAPY; MALE; MYOCARDIAL INFARCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 34247169921     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.01.027     Document Type: Article

References (31)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. International Society for Heart and Lung Transplantation. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
2. Colvin R.B., and Smith R.N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 10 (2005) 807-817
3. Kfoury A.G., Stehlik J., Renlund D.G., et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant 25 (2006) 1277-1282
4. Reed E.F., Demetris A.J., Hammond E., et al. Acute Antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153-159
5. Smith R.N., Brousaides N., Grazette L., et al. C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant 24 (2005) 1202-1210
6. Michaels P.J., Espejo M.L., Kobashigawa J., et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58-69
7. Taylor D.O., Yowell R.L., Kfoury A.G., Hammond E.H., and Renlund D.G. Allograft coronary artery disease clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 19 (2000) 518-521
8. Tambur A.R., Pamboukian S.V., Constanzo M.R., et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 80 (2005) 1019-1025
9. Jordan S.C., Vo A.A., Tyan D., Nast C.C., and Toyoda M. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant 9 (2005) 408-415
10. Becker Y.T., Samaniego-Picota M., and Sollinger H.W. The emerging role of rituximab in organ transplantation. Transpl Int 19 (2006) 621-628
11. Olivari M.T., May C.B., Johnson N.A., Ring W.S., and Stephens M.K. Treatment of acute vascular rejection with immunoadsorption. Circulation 90 (1994) II70-II73
12. Bohmig G.A., Regele H., Exner M., et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 12 (2001) 2482-2489
13. Soleimani B., Lechler R.I., Hornick P.I., and George A.J. Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation. Am J Transplant 6 (2006) 1781-1785
14. Joyce D.L., Southard R.E., Torre-Amione G., Noon G.P., Land G.A., and Loebe M. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant 24 (2005) 2054-2059
15. Baran D.A., Gass A.L., Galin I.D., et al. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device. J Heart Lung Transplant 24 (2005) 1886-1890
16. Groetzner J., Meiser B., Landwehr P., et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 77 (2004) 568-574
17. Rastetter W., Molina A., and White C.A. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 55 (2004) 477-503
18. Smith M.R. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene 22 (2003) 7359-7368
19. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., and Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5 (2005) 145-148
20. Bucin D., Johansson S., Malm T., et al. Heart transplantation across the antibodies against HLA and ABO. Transpl Int 19 (2006) 239-244
21. Pierson III R.N., Loyd J.E., Goodwin A., et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 74 (2002) 79-84
22. Banner N.R., Rose M.L., Cummins D., et al. Management of an ABO-incompatible lung transplant. Am J Transplant 4 (2004) 1192-1196
23. Garrett Jr. H.E., Groshart K., Duvall-Seaman D., Combs D., and Suggs R. Treatment of humoral rejection with rituximab. Ann Thorac Surg 74 (2002) 1240-1242
24. Aranda Jr. J.M., Scornik J.C., Normann S.J., et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 73 (2002) 907-910
25. Baran D.A., Lubitz S., Alvi S., et al. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab. Transplant Proc 36 (2004) 3164-3166
26. Keren A., Hayes H.M., and O'Driscoll G. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab. Transplant Proc 38 (2006) 1520-1522
27. Garrett H.E., Duvall-Seaman D., Helsley B., and Groshart K. Treatment of vascular rejection with rituximab in cardiac transplantation. J Heart Lung Transplant 24 (2005) 1337-1342
28. Balfour I.C., Fiore A., Graff R.J., and Knutsen A.P. Use of rituximab to decrease panel-reactive antibodies. J Heart Lung Transplant 24 (2005) 628-630
29. Solal-Celigny P. Safety of rituximab maintenance therapy in follicular lymphomas. Leuk Res 30 suppl 1 (2006) S16-S21
30. Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31 (2005) 456-473
31. Hershko A.Y., and Naparstek Y. Removal of pathogenic autoantibodies by immunoadsorption. Ann N Y Acad Sci 1051 (2005) 635-646